Sort
16,179 grants matching “malaria”
Core 1: Facility Management, Maintenance and Operations Core
$953,343Colin S. Duckett · Duke University · UC7 · FY2024 · AI
Genomic Characterization and Surveillance of Microbial Threats in West Africa
$953,032Christian T. Happi · Redeemer'S University · U54 · FY2017 · HG
Boron-containing antimalarial drug discovery
$952,800Steve Baker · Reactive Biosciences Inc · R44 · FY2023 · AI
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
$952,577Sanjay Rajagopalan · Case Western Reserve University · R35 · FY2024 · ES
Adaptations Of Borrelia Spirochetes To Their Tick Vectors And Mammalian Hosts
$951,648Tom Schwan · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Telomere Structure In Drosophila
$951,540James M Mason · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Universal Attenuated Sporozoite Vaccine and Challenge System
$951,398Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2018 · AI
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$951,181Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Malaria Parasite Ligands And Host Cell Receptors
$950,802Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Human Dendritic Cell Subsets
$950,220Jacques F Banchereau · Baylor Research Institute · U19 · FY2008 · AI
Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection
$949,793Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Clinical & Molecular Studies of Drug Resistant Malaria
$948,773Philip Jon Rosenthal · University Of California, San Francisco · U01 · FY2006 · AI
International Clinical Trials Unit
$948,184John A Bartlett · Duke University · U01 · FY2007 · AI
Defining the immunogenic landscape of early mosquito-stage P. falciparum to accelerate malaria transmission-blocking vaccine discovery
$947,948Kristian Edward Swearingen · Institute For Systems Biology · R01 · FY2025 · AI
In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine
$947,054Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2022 · AI
Uncovering the parasite and host determinants of Plasmodium vivax hypnozoite formation and development using single cell sequencing and human liver-chimeric mice
$946,707Ashley M Vaughan · Seattle Children'S Hospital · R01 · FY2022 · AI
Host Immune Responses to Antigens of Malaria Parasites
$946,156Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines
$945,493Stephen Lev Hoffman · Sanaria, Inc. · U01 · FY2025 · AI
Clinical Studies of Interactions Between HIV and Malaria
$945,312University Of California San Francisco · U01 · FY2005 · AI
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
$945,000Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2022 · DA
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
$945,000Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2020 · DA
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
$945,000Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2021 · DA
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
$945,000Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2023 · DA
PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response.
$943,229Iain James Macleod · Aldatu Biosciences, Inc. · R44 · FY2024 · AI
Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines
$942,943Stephen Lev Hoffman · Sanaria, Inc. · U01 · FY2022 · AI